Edition:
United Kingdom

Natera Inc (NTRA.OQ)

NTRA.OQ on NASDAQ Stock Exchange Global Select Market

11.11USD
19 Jan 2018
Change (% chg)

$0.81 (+7.86%)
Prev Close
$10.30
Open
$10.24
Day's High
$11.16
Day's Low
$10.24
Volume
38,942
Avg. Vol
51,587
52-wk High
$14.69
52-wk Low
$7.38

Chart for

About

Natera, Inc. is a diagnostics company. The Company is engaged in the discovery, development and commercialization of genetic testing services. It offers Panorama Non-Invasive Prenatal Test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother; Horizon Carrier Screening to determine carrier... (more)

Overall

Beta: --
Market Cap(Mil.): $761.62
Shares Outstanding(Mil.): 53.22
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 32.28 16.58
EPS (TTM): -- -- --
ROI: -- 13.90 10.60
ROE: -- 16.71 14.19

BRIEF-James Flynn Reports 5.17 Percent Passive Stake In Natera Inc

* JAMES FLYNN REPORTS 5.17 PERCENT PASSIVE STAKE IN NATERA INC AS OF DECEMBER 1 - SEC FILING Source text: (http://bit.ly/2AdxG42) Further company coverage:

11 Dec 2017

BRIEF-Natera reports third quarter loss of $0.51 per share

* Q3 earnings per share view $-0.48 -- Thomson Reuters I/B/E/S

08 Nov 2017

BRIEF-Natera enters into credit agreement by and between Natera and Orbimed Royalty Opportunities

* Natera - on August 8 entered into credit agreement by and between Natera as the borrower and Orbimed Royalty Opportunities II, Lp as lender - sec filing

10 Aug 2017

BRIEF-Natera Q2 loss per share $0.52

* Q2 earnings per share view $-0.54 -- Thomson Reuters I/B/E/S

08 Aug 2017

Earnings vs. Estimates